Finding our way through the labyrinth of dementia biomarkers.
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Amyloid-imaging does not allow for differentiation between distinct amyloid-positive disorders, and positive...
| Published in: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 48; no. 8; pp. 2320 - 2325 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
Jul2021
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=152814348&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 152814348 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 16197070 NPC jtl: European Journal of Nuclear Medicine & Molecular Imaging issn: 16197070 maglogo: N pubinfo: dt: Jul2021 vid: 48 iid: 8 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 152814348 149874986 10.1007/s00259-021-05301-7 152814348 ppf: 2320 ppct: 5 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Finding our way through the labyrinth of dementia biomarkers. aug: au: Chételat, Gaël Arbizu, Javier Barthel, Henryk Garibotto, Valentina Lammertsma, Adriaan A. Law, Ian Morbelli, Silvia van de Giessen, Elsmarieke Drzezga, Alexander affil: Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France sug: ab: The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Amyloid-imaging does not allow for differentiation between distinct amyloid-positive disorders, and positive amyloid scans are found in about one third of cognitively unimpaired elderly with yet unknown clinical relevance [[11]]. This article is part of the Topical Collection on Neurology In 1984, consensual criteria for Alzheimer's disease (AD) were published, which were fully based on symptoms as tracked by clinical and neuropsychological examinations [[1]]. From there, an amyloid-PET scan could be proposed only in cases who do not show an FDG-PET pattern typical for a specific diagnosis, if atypical AD is possible or if the amyloid status is required. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|